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Abstract
Background: The ability to measure 25-hydroxyvitamin D (25OHD) levels from blood spot cards can simplify sample
collection versus samples obtained by venipuncture, particularly in populations in whom it is difficult to draw blood. We
sought to validate the use of blood spot samples for the measurement of 25OHD compared to serum or whole blood
samples and correlate the measured levels with intake estimated from dietary recall.
Methods: Utilizing 109 biological mothers of infants enrolled in the Tennessee Children’s Respiratory Initiative cohort, we
measured 25OHD levels through highly selective liquid chromatography–tandem mass spectrometry on samples from
blood spot cards, serum, and whole blood collected at enrollment. Dietary questionnaires (n=65) were used to assess
25OHD intake by dietary recall. Sample collection measures were assessed for agreement and 25OHD levels for association
with dietary 25OHD intake.
Results: The mean absolute differences (95%CI) in 25OHD levels measured between whole blood and blood spot (n=50
pairs) or serum and blood spot (n=20) were 3.2 (95%CI:1.6, 4.8) ng/ml and 1.5 (95%CI:20.5,3.4) ng/mL. Intake by dietary
recall was marginally associated with 25OHD levels after adjustment for current smoking and race in linear regression.
Discussion: 25OHD levels determined by mass spectrometry from blood spot cards, serum and whole blood show relatively
good agreement, although 25OHD levels are slightly lower when measured by blood spot cards. Blood spot samples are a
less invasive means of obtaining 25OHD measurements, particularly in large population-based samples, or among children
when venipuncture may decrease study participation.
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Introduction
Vitamin D is becoming recognized for the biological role played
in development of a wide variety of conditions including bone
fractures[1], resistance to microbial infections[2], cardiovascular
disease [3,4], cancer[5] and asthma[6,7]. Vitamin D can come
from dietary sourcesincluding fortified foods and supplements.
More abundantly, vitamin D is synthesized from 7-dehydrocho-
lesterol by ultraviolet B exposure to the skin and converted to a
measurable circulating metabolite 25-hydroxy vitamin D
(25OHD) in the liver. Total 25OHD has 25-hydroxy vitamin D2
and 25-hydroxy D3 as its constituent parts.
There has been longstanding debate in the literature about how to
accurately measure 25OHD [8–10]. The lipophilic hydrophobic
properties of vitamin D, coupled with its tight affinity to vitamin D
binding protein, have made it challenging to measure. Early
techniques to detect 25OHD include competitive binding protein
assays [11,12] which are susceptible to matrix effects and cross-
reactivity with other Vitamin D metabolites and can bias
measurement of 25OHD [8]. Other enzyme immunoassays and
chemiluminescence based tests [13,14] have been automated for
large scale processing to handle the increased demand of clinical
testing, whichwere not possible with the gas chromatographic or high
performance liquid chromatography methods, both of which have
been considered the best tools for 25OHD measurement [15–18].
More recently, highly selective liquid chromatography–tandem mass
spectrometry (LC-MS/MS) is emerging as a respected assay due to its
high specificity in teasing apart 25OHD2 and 25OHD3.[15,19]
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difficult to collect in large epidemiological studies or among
populations in whom blood draws decrease study participation,
such as in infants and children. For this reason, we sought to
evaluate the agreement in measurement of vitamin D by LC-MS/
MS from a blood spot card, prepared in the lab with vitamin D
measurements by LC-MS/MS from serum or whole blood
samples. We also wanted to assess whether a food frequency
questionnaire that estimated dietary vitamin D intake provided an




The Tennessee Children’s Respiratory Initiative is a longitudi-
nal study of mother-infant dyads designed to understand the
relationship between infant respiratory infections and asthma and
atopic diseases. Term, non-low birth weight previously healthy
infants and their biological mothers were enrolled during infancy
during 2004–2008, when the infant was treated for viral lower or
upper respiratory tract infection (N=630), as has been previously
described.[20] A subset of 109 mothers with available blood
specimens had their 25-hydroxyvitamin D levels determined
through the use of laboratory created blood spot cards. Forty-
seven percent (50/109) of these women had their 25OHD levels
additionally assayed through the use of whole blood and 19% (20/
109) had levels assayed using an available serum sample. Maternal
samples were collected only during the fall, winter and spring
seasons, reflecting the study enrollment periods during viral
seasons.
This research was approved by the Institutional Review Board
at Vanderbilt University. Written informed consent was obtained
from participants within this study.
Blood Spot preparation
In the laboratory, using whole blood specimens stored at 280
degrees from mothers in the study, between 3 and 12 non-
overlapping drops of the whole blood were pipetted onto
laboratory provided blood spot cards with a pre-stamped circle.
Blood spots were air dried for at least 30 minutes before closing the
flap on the blood spot card. Fully dried samples were refrigerated
and sent in batches to ZRT Laboratory, (Beaverton, OR) for
vitamin D assay.
Measurement of 25OHD
25-OHD was extracted from 6mm spots and derivatized for
analysis by LC-MS/MS using previously described methods
[21,22] which were modified to allow for automation. Spots were
punched from dried blood spot cards (Wallac MultiPuncher) and
reconstituted with 600 ul of deionized water. 600 ul of methanol
containing internal standard (D4-25-hydroxyvitamin D3) was
then added to precipitate proteins and the samples were
vortexed. 900 ul of the supernatant was extracted with C18
solid phase extraction. Extracted samples were derivatized with
200 ul of 0.1 mg/ml PTAD (4-phenyl-1,2,4-triazoline-3,5-dione)
at room temperature for 10 minutes. Derivatized samples were
blown to dryness with nitrogen and reconstituted with 50 ul of
methanol and 20 ul injected into the LC-MS/MS system
(Varian). The vitamin D assay was repeated by ZRT labs using
the above procedure with 20 uL of whole blood or 10 ul serum
for comparison. Separate calibrations were run for each sample
type.
Vitamin D Dietary Intake Ascertainment
The Block 2000 Brief Food Questionnaire (Block Dietary Data
Systems, Berkeley, California) was available on 65 women who
also had available blood spot samples from the enrollment visit.
This 70 item test asks about usual eating habits in the past year as
well as about multivitamin supplementation, from which vitamin
D dietary intake is calculated. It is based on an earlier validated
brief food frequency questionnaire[23]. A composite variable
representing total vitamin D intake was created by summing the
food and supplement amounts of vitamin D.
Variable Definition
25OHD levels were analyzed as continuous measures and
subjects were also grouped in categories defined as: sufficient
$30 ng/mL, insufficient, $20–29 ng/mL and deficient ,20 ng/
mL. These categories were selected from Holick 2007 who
synthesized existing expert opinion with biologic evidence from
observed relationships between parathyroid hormone and vitamin
D and calcium transport and Vitamin D [24]. Ethnicity and
education were dichotomized into European-American and non
European-American groups and high school graduate or less
compared to college attendance. Maternal season of study for time
of vitamin D ascertainment was categorized as fall (September
through November), winter (December through February) or
spring (March through May) with no recruitment during the
summer non-viral seasons.
Statistical Methods
We compared the agreements of results between vitamin D
measurements by LC-MS/MS utilizing blood spot samples, whole
blood samples, or serum samples in two ways. First, we used Bland
Altman plots with vitamin D means plotted on the horizontal axis
and the differences plotted on the vertical axis for visual inspection
of the amount of disagreement between the two measures.
Horizontal lines are drawn at the mean difference, and at the
limits of agreement, which are defined as the mean difference plus
and minus 1.96 times the standard deviation of the differences.
Next, we calculated the absolute difference and the percent
difference between the sample types to estimate systematic bias.
We used paired t-test difference analysis with log transformation of
25OHD levels. We also assessed correlations between the different
measures using Spearman rank correlation coefficient; all pairwise
Spearman correlation coefficients were $0.9, p,0.001. We used
the binomial Wilson approximation for calculation of 95%
confidence interval of proportions by category definitions [25].
Multivariable linear regression was used to assess the association
between vitamin D intake and 25OHD levels by blood spot after
adjusting for a priori chosen covariates including maternal age,
maternal race and current smoking. The association of serum
25OH by blood spot with Vitamin D intake was analyzed using
separate models from food sources, from supplements and the
sum. Maternal 25OHD levels were log transformed for normality.
In addition we performed Box-Cox power transformation as a
sensitivity analysis. As results were similar, we present log
transformed analysis for ease of beta coefficient interpretation.
Results
The characteristics of the study population are described in
Table 1. Of the 109 women with 25OHD levels measured utilizing
whole blood spot cards, there were 50 women with both blood
spot and whole blood samples and 20 women with serum and
whole blood samples, or serum and blood spot samples. For all 109
samples, the mean maternal age was 26.566.6 SD years.
Measuring Vitamin D Levels by Blood Spot Cards
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30% were smokers. Sixty percent of maternal measurements were
obtained during winter months. Population characteristics did not
vary by the subset of available data.
Total vitamin D levels, measured by blood spot cards,
averaged 25612 ng/mL. All of the 25OHD2 levels were
,4 ng/mL and, thus, the total 25OHD values consist almost
entirely of 25OHD3 levels. Sixty-five mothers had available
paired food frequency questionnaire (FFQ) data and available
blood spot vitamin D measures. The average dietary intake of
vitamin D from food sources was 151.06114.2 IU. The median
supplemental intake was 0 with an interquartile range [IQR] of
[0–400 IU]. The composite measure of total vitamin D intake
was 3316238 IU.
Agreement in 25OHD measurements using blood spot, serum
and whole blood samples were evaluated using Bland-Altman
plots, and are presented in figures 1 and 2. In the serum versus
blood spot comparison of figure 1, only one point falls out the two
standard deviation interval. Blood spot measurements were on
average 1.1 ng/mL lower with a 3.3 percent difference that was
not statistically significant (95% CI: 26.3–12.1%; p=.48).
Similarly in figure 2, only 2 observations fell outside of the two
standard deviation bounds for blood spot and whole blood
measurements. The blood spot 25OHD measurements were on
average 3.2 ng/mL lower than whole blood, which corresponds to
an 11% difference (95% CI: 3.8%–18.3%; p=0.003).
Sixty five mothers had both food frequency questionnaire data
on vitamin D dietary intake and biospecimens available for
measurement of vitamin D levels utilizing blood spot cards.
Dietary intake of vitamin D by 24 hour recall was not associated
with vitamin D levels in either univariate analyses or multivariable
regression, after adjusting for maternal age, smoking, and race.
Table 2 shows the parameter estimates for models that consider
dietary intake from food, dietary intake from supplements, and
dietary intake from the sum of food and supplemental intake in
separate regression models. Log transformed vitamin D intake was
marginally associated with a 0.24 ng/mL increase in 25OHD
levels (p=0.05). However when we applied Box Cox transforma-
tion for normality of residuals of multivariable linear regression,
the statistical significance was attenuated (p=0.08).
Discussion
This study examines the agreement between vitamin D
measurements by LC-MS/MS comparing dried blood spot, serum
and whole blood samples. Measurement of vitamin D using the
three specimen types showed good, though imperfect, agreement.
The measurement of vitamin D using blood spot card samples is a
reliable means of collecting and measuring vitamin D levels. Blood
spot measurements were on average lower than both whole blood
and serum measurements. In the absence of a gold standard, we
can assess extent of differences, but we do not have a known true
Table 1. Subject Characteristics of Mothers with Vitamin D Measurements Determined by LCMS/MS Used in Pairwise Comparisons.
Characteristic N (%) or Mean (SD)
Number of mothers with blood spot cards and whole blood N=50
Number of mothers with blood spot cards and serum N=20
Number of mothers with blood spot cards and food frequency questionnaires N=65
Mean maternal age at measurement 27.4 (5.6)
Race
European-American 90 (83%)




Current maternal smoking 30 (28%)
Education
$12 years of education 83 (83%)
,12 years 17 (17%)
Mean weeks postpartum 14 (12)
Mean 25OHD levels, ng/mL 25 (12)
Vitamin D status based on blood spot (N=109)
Sufficient $30 ng/mL 30 (28%)
Insufficient: 20–30 ng/mL 37 (34%)
Deficient ,20 ng/mL 42 (39%)
Mean dietary intake, IU 151 (114)
Supplemental use (N=65)
None 33 (51%)
1–399 IU 9 (16%)
$400 IU 23 (36%)
Supplemental + diet mean intake, IU 331 (238)
doi:10.1371/journal.pone.0016602.t001
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example. However, the results are consistent at both higher and
lower levels, thus the relative vitamin D measurements are
consistent across a spectrum of values.
The highest difference observed (11%) was between blood spot
and whole blood levels, where the whole blood levels may not have
adequately been corrected for the whole blood hematocrit.
Alternatively, it is possible that some degradation of vitamin D
Figure 1. Bland-Altman plots of 25OHD measurements comparing blood spot cards to serum, using liquid chromatography–
tandem mass spectrometry.
doi:10.1371/journal.pone.0016602.g001
Figure 2. Bland-Altman plots of 25OHD measurements comparing blood spot cards to whole blood, using liquid chromatography–
tandem mass spectrometry.
doi:10.1371/journal.pone.0016602.g002
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suggested by Eyles et al (2010), who demonstrated excellent
correlation between cord blood 25OHD levels compared to dried
blood spot cards [26]. Because whole blood was available on a
larger number of samples, it provided additional information in
evaluating dried blood spots. We note that the most relevant
comparison is between serum and blood spot samples because
both these assays are commercially available and run routinely.
For purposes of epidemiological studies, rather than clinical
diagnoses, an average difference of 1.1 ng/mL based on the
difference between serum and blood spot cards may not
substantially affect the prevalence of insufficiency and deficiency.
The point estimates and 95% confidence intervals for the
prevalences of sufficiency (28% 95%CI: 20–37%), insufficiency
(34% 95%CI: 26–43%) and deficiency (39% 95% CI: 30–48%)
overlap with point estimates when a constant of 1.1 is added to
address the lower values of blood spots relative to serum levels
(32%, 34%, 34% respectively). Furthermore, a categorization
approach assumes that the threshold values are intractable, when
commentary has begun to suggest that the reference ranges for
optimal benefit may be too low [27] and depend on the disease or
population characteristics being studied. Based on current studies,
theInstitute of Medicine even suggested the opposite, that levels
greater than or equal to 20 ng/mL are sufficient for bone health
where causality has been strongly established [28]. It has even
been proposed that thresholds be determined by assay type that
accounts for measurement variability [29]. The findings from this
study would support such an approach.
Many prior analyses have explored the relationship between
vitamin D measurements conducted using different assay types
[9,16,30–32]. For example, a comparison of 25OHD levels from
serum measured on HPLC, LC-MS/MS, and RIA, showed inter-
assay differences of 2.9 to 5.1 ng/mL, where LC-MS/MS and
RIA methods were higher than HPLC[32]. A calibration equation
that corrected for the systematic bias did not entirely eliminate the
inter-laboratory differences. A similar upward bias was seen
comparing LC-MS/MS to seven commercially available assays
and also concluded that calibration did not eliminate interassay
differences [33]. The National Institute of Standards and
Technology has developed a standard measurement (certified in
July 2009) that will help improve the measurement of vitamin D
by encouraging inter-laboratory consistency agreement. This
standard was not available at the time the samples were run.
Because maternal dietary vitamin D intake was also available,
we determined the agreement in dietary intake as determined by
food frequency questionnaires with measured vitamin D levels. In
this population, the major source of vitamin D was D3, converted
by the skin from sunlight exposure. While measurements were
broken down by the 25OHD2 and 25OHD3 components, all the
vitamin 25OHD2 measurements were below the minimum
detectable level. Thus, dietary intake information using FFQs in
this population did not correlate with measured vitamin D levels,
likely because the major source of vitamin D in this population is
sunlight and not food sources. Such a finding is consistent with
other studies that have found a low correlation between dietary
intake and serum levels[34,35].
In this study, we used a single sample to measure vitamin D levels.
Several studies have demonstrated that season of measurement
explains the greatest variability in vitamin D measurements.
However, in studies that have compared vitamin D measurements
at several seasonal time points, the correlation between two measures
was high 0.55–0.80 and was greatest when measured 1 year apart
during the same season [36]. Measurements taken over 14 years also
demonstrated correlations of .39–0.52, with most individuals at the
extreme quintiles remaining in the same quintile over time[36].
This study has several limitations. Blood spot cards were
prepared in the laboratory and not tested in the field using a finger
or heel prick, and this could change the results. In this analysis,
25OHD2 levels were less than the detectable limit (4 ng/mL), and,
thus, results driven by the 25OHD3. The lack of detection of
25OHD2 in our study is likely to be due to the lack of high
supplementation in the population, which was noted on the food
frequency questionnaire, because of this, however, assessment of
the agreement of 25OHD2 can therefore not be made in this
study. In a study conducted by ZRT Laboratory, which looked at
25OHD2 and 25OHD3 levels in blood spot cards, the authors find
evidence suggesting that there is proportional bias with 25OHD2
blood spot cards compared to serum [22].
Blood spot cards enable an easy, safe, and practical way to screen
for vitamin D deficiencies in at-risk populations where venipuncture
is impractical including, elderly and pediatric populations, rural
clinics, and developing countries. The assay variability due to the
type of specimen analyzed was comparable to variability observed
when comparing across laboratory methods. The introduction of
thestandardwill certainlyassistinaddressinglaboratorydifferences,
calibrating vitamin D measurements to better measure true
underlying levels. Blood spot cards also brings us one significant
step closer to mass screening for vitamin D deficiency, something
that has so far not been practical despite the great importance of
vitamin D to the health of the skeletal, immune, and cardiovascular
systems in all phases of the human life cycle.
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